Sayers T J, Macher I, Chung J, Kugler E
J Immunol. 1987 May 1;138(9):2935-40.
Lipid X, a monosaccharide biosynthetic precursor of lipid A, has been chemically synthesized and was shown to induce bone marrow-derived macrophages to release tumor necrosis factor (TNF) in vitro. However, relatively high amounts of lipid X were necessary for induction, and the levels of TNF were much less than those induced by small amounts of lipid A itself or LPS. Lipid X prepared by extraction of Escherichia coli mutants induced higher levels of TNF than the chemically synthesized material, but this is probably partially due to amounts of impurities in the extracted material. Pretreatment of macrophages with IFN-gamma resulted in the release of higher amounts of TNF on subsequent induction with either LPS or lipid X. In contrast, pretreatment of macrophages with LPS induced hyporesponsiveness for TNF production on subsequent rechallenge with LPS. Lipid X, on the other hand, was incapable of making macrophages hyporesponsive for TNF production.
脂质X是脂多糖A的单糖生物合成前体,已被化学合成,并被证明可在体外诱导骨髓来源的巨噬细胞释放肿瘤坏死因子(TNF)。然而,诱导过程需要相对大量的脂质X,且TNF水平远低于少量脂多糖A本身或脂多糖诱导产生的水平。通过提取大肠杆菌突变体制备的脂质X比化学合成的材料诱导出更高水平的TNF,但这可能部分归因于提取物中的杂质含量。用γ干扰素预处理巨噬细胞,随后用脂多糖或脂质X诱导时会释放出更高量的TNF。相反,用脂多糖预处理巨噬细胞会使其在随后再次接触脂多糖时对TNF产生低反应性。另一方面,脂质X无法使巨噬细胞对TNF产生低反应性。